KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Non-Current Assets (2016 - 2025)

Amgen (AMGN) has 17 years of Non-Current Assets data on record, last reported at $62.3 billion in Q3 2025.

  • For Q3 2025, Non-Current Assets fell 2.9% year-over-year to $62.3 billion; the TTM value through Sep 2025 reached $248.7 billion, down 4.21%, while the annual FY2024 figure was $62.8 billion, 6.01% down from the prior year.
  • Non-Current Assets reached $62.3 billion in Q3 2025 per AMGN's latest filing, up from $61.2 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $66.8 billion in Q4 2023 and bottomed at $39.6 billion in Q3 2022.
  • Average Non-Current Assets over 5 years is $50.8 billion, with a median of $42.9 billion recorded in 2022.
  • Peak YoY movement for Non-Current Assets: soared 55.64% in 2023, then decreased 6.01% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $41.8 billion in 2021, then rose by 2.76% to $42.9 billion in 2022, then skyrocketed by 55.64% to $66.8 billion in 2023, then dropped by 6.01% to $62.8 billion in 2024, then fell by 0.88% to $62.3 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $62.3 billion in Q3 2025, $61.2 billion in Q2 2025, and $62.4 billion in Q1 2025.